{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:52:21Z","timestamp":1790797941429,"version":"4.1.0"},"reference-count":62,"publisher":"Impact Journals, LLC","issue":"57","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,14]]},"DOI":"10.18632\/oncotarget.22107","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T09:52:05Z","timestamp":1509357125000},"page":"97344-97360","source":"Crossref","is-referenced-by-count":15,"title":["Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid"],"prefix":"10.18632","volume":"8","author":[{"given":"Christian","family":"Bressy","sequence":"first","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragomira","family":"Majhen","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najat","family":"Raddi","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Jdey","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00e9tan","family":"Cornilleau","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9na","family":"Zig","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Guirouilh-Barbat","sequence":"additional","affiliation":[{"name":"Laboratoire Recombinaison-R\u00e9paration et Cancer, UMR 8200 CNRS Stabilit\u00e9 G\u00e9n\u00e9tique et Oncogen\u00e8se, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard S.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Laboratoire Recombinaison-R\u00e9paration et Cancer, UMR 8200 CNRS Stabilit\u00e9 G\u00e9n\u00e9tique et Oncogen\u00e8se, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Bawa","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de pathologie exp\u00e9rimentale de l\u2019IRCIV, Gustave Roussy, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paule","family":"Opolon","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de pathologie exp\u00e9rimentale de l\u2019IRCIV, Gustave Roussy, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Grellier","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benihoud","sequence":"additional","affiliation":[{"name":"Vectorologie et Th\u00e9rapeutiques Anticanc\u00e9reuses, UMR 8203 CNRS, Universit\u00e9 Paris-Sud, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif 94805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Pox","year":"2014","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Curiel","year":"2010","journal-title":"Mol Ther"},{"key":"3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.molmed.2012.04.008","article-title":"Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond","volume":"18","author":"Nettelbeck","year":"2012","journal-title":"Trends Mol Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1158\/0008-5472.CAN-06-2871","article-title":"Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions","volume":"67","author":"Kirn","year":"2007","journal-title":"Cancer Res"},{"key":"5","first-page":"1193","article-title":"antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy","volume":"60","author":"Kirn","year":"2000","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect","volume":"19","author":"Kyritsis","year":"2000","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Kirn","year":"2000","journal-title":"Nat Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1158\/1535-7163.MCT-05-0374","article-title":"Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment","volume":"5","author":"Hoffmann","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1200\/JCO.2003.09.114","article-title":"Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer","volume":"21","author":"Hamid","year":"2003","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.cgt.7700988","article-title":"Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver","volume":"14","author":"Reid","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"11","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1158\/1535-7163.MCT-09-0556","article-title":"Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses","volume":"8","author":"Hoffman","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Bell","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ymthe.2004.12.015","article-title":"Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, Soluble Flt-1","volume":"11","author":"Liu","year":"2005","journal-title":"Mol Ther"},{"key":"14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/sj.cgt.7700579","article-title":"Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon","volume":"10","author":"Deisseroth","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bcp.2014.05.003","article-title":"Association of oncolytic adenoviruses with chemotherapies: an overview and future directions","volume":"90","author":"Benihoud","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Kirn","year":"1997","journal-title":"Nat Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-05-0309","article-title":"RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer","volume":"65","author":"Iggo","year":"2005","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.cgt.7700726","article-title":"Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells","volume":"11","author":"Rodriguez","year":"2004","journal-title":"Cancer Gene Ther"},{"key":"19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ijc.24700","article-title":"HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model","volume":"126","author":"Mulherkar","year":"2010","journal-title":"Int J Cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/epi.3.1.5736","article-title":"HDACs and HDAC inhibitors in colon cancer","volume":"3","author":"Mariadason","year":"2008","journal-title":"Epigenetics"},{"key":"21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","article-title":"Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis","volume":"5","author":"G\u00f6ttlicher","year":"2004","journal-title":"Cancer Cell"},{"key":"22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Xu","year":"2009","journal-title":"J Cell Biochem"},{"key":"23","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"G\u00f6ttlicher","year":"2003","journal-title":"EMBO J"},{"key":"24","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/ijc.24158","article-title":"Valproic acid enhances bosutinib cytotoxicity in colon cancer cells","volume":"124","author":"Gambacorti-Passerini","year":"2009","journal-title":"Int J Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2407-4-92","article-title":"Role of the p53\/p21 system in the response of human colon carcinoma cells to doxorubicin","volume":"4","author":"Monti","year":"2004","journal-title":"BMC Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.ejca.2010.03.021","article-title":"Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy","volume":"46","author":"Willems","year":"2010","journal-title":"Eur J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1128\/JVI.00091-09","article-title":"Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication","volume":"83","author":"Ornelles","year":"2009","journal-title":"J Virol"},{"key":"29","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-11-0767","article-title":"Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy","volume":"18","author":"Minucci","year":"2012","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2008.06.005","article-title":"Histone deacetylase inhibitors and genomic instability","volume":"274","author":"Jaulin","year":"2009","journal-title":"Cancer Lett"},{"key":"31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Ahmad","year":"2007","journal-title":"FASEB J"},{"key":"32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","article-title":"Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial","volume":"97","author":"J\u00e4ger","year":"2007","journal-title":"Br J Cancer"},{"key":"33","first-page":"4273","article-title":"Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors","volume":"62","author":"Curiel","year":"2002","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1158\/0008-5472.CAN-05-4672","article-title":"Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application","volume":"66","author":"Pong","year":"2006","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.yexcr.2005.10.026","article-title":"Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells","volume":"312","author":"Tanaka","year":"2006","journal-title":"Exp Cell Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/cgt.2012.57","article-title":"Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells","volume":"19","author":"Fujiwara","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3892\/ijmm.2012.1133","article-title":"Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer","volume":"30","author":"Dong","year":"2012","journal-title":"Int J Mol Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/hum.2006.17.55","article-title":"Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520","volume":"17","author":"Holm","year":"2006","journal-title":"Hum Gene Ther"},{"key":"39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ymthe.2006.07.009","article-title":"Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy","volume":"14","author":"Rodriguez","year":"2006","journal-title":"Mol Ther"},{"key":"40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jgm.2703","article-title":"Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma: effects of antiepileptics on Delta24RGD","volume":"15","author":"Lamfers","year":"2013","journal-title":"J Gene Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ijc.25367","article-title":"Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy","volume":"128","author":"Kloog","year":"2011","journal-title":"Int J Cancer"},{"key":"42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.cdd.4400706","article-title":"Procaspase 3\/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A.","volume":"7","author":"Akahane","year":"2000","journal-title":"Cell Death Differ"},{"key":"43","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.4161\/cc.8.24.10215","article-title":"Pseudo-DNA damage response in senescent cells","volume":"8","author":"Blagosklonny","year":"2009","journal-title":"Cell Cycle"},{"key":"44","doi-asserted-by":"publisher","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-06-0887","article-title":"Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1677\/ERC-10-0234","article-title":"AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947","volume":"18","author":"Portella","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"46","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1158\/0008-5472.CAN-08-0817","article-title":"Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis","volume":"68","author":"McNeish","year":"2008","journal-title":"Cancer Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/onc.2010.335","article-title":"Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer","volume":"29","author":"McNeish","year":"2010","journal-title":"Oncogene"},{"key":"48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature09803","article-title":"HDACs link the DNA damage response, processing of double-strand breaks and autophagy","volume":"471","author":"Foiani","year":"2011","journal-title":"Nature"},{"key":"49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature00863","article-title":"Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex","volume":"418","author":"Weitzman","year":"2002","journal-title":"Nature"},{"key":"50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/viro.1999.9866","article-title":"Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase","volume":"263","author":"Ketner","year":"1999","journal-title":"Virology"},{"key":"51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-cellbio-092910-154234","article-title":"The causes and consequences of polyploidy in normal development and cancer","volume":"27","author":"de Lange","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"52","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1128\/JVI.00029-07","article-title":"Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation","volume":"81","author":"Ketner","year":"2007","journal-title":"J Virol"},{"key":"53","doi-asserted-by":"publisher","first-page":"e11208","DOI":"10.1371\/journal.pone.0011208","article-title":"Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor","volume":"5","author":"Nortier","year":"2010","journal-title":"PLoS One"},{"key":"54","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3892\/ijo.2012.1416","article-title":"Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma","volume":"40","author":"Harada","year":"2012","journal-title":"Int J Oncol"},{"key":"55","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1128\/MCB.00479-09","article-title":"The Mre11 complex and the response to dysfunctional telomeres","volume":"29","author":"Petrini","year":"2009","journal-title":"Mol Cell Biol"},{"key":"56","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.cub.2004.07.019","article-title":"The Drosophila Mre11\/Rad50 complex is required to prevent both telomeric fusion and chromosome breakage","volume":"14","author":"Gatti","year":"2004","journal-title":"Curr Biol"},{"key":"57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins","volume":"11","author":"Blasco","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"58","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1016\/j.febslet.2010.07.029","article-title":"The MRN complex in double-strand break repair and telomere maintenance","volume":"584","author":"Weitzman","year":"2010","journal-title":"FEBS Lett"},{"key":"59","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1038\/oncsis.2013.35","article-title":"Epigenetic and genetic features of 24 colon cancer cell lines","volume":"2","author":"Lothe","year":"2013","journal-title":"Oncogenesis"},{"key":"60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.gt.3301845","article-title":"Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation","volume":"10","author":"Yeh","year":"2003","journal-title":"Gene Ther"},{"key":"61","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/gt.2009.97","article-title":"Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid","volume":"16","author":"Benihoud","year":"2009","journal-title":"Gene Ther"},{"key":"62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.gt.3302885","article-title":"Respective roles of TNF-\u03b1 and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice","volume":"14","author":"Saggio","year":"2007","journal-title":"Gene Ther"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:29:50Z","timestamp":1589207390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":62,"journal-issue":{"issue":"57","published-print":{"date-parts":[[2017,11,14]]}},"alternative-id":["22107","29228615"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22107","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}